TNON TENON MEDICAL INC revenue, earnings and financials
For the quarter ended June 30, 2026, TENON MEDICAL INC reported revenue of $1.28M (up 126.8% from a year earlier), net income of −$4.05M and diluted EPS of −$12.35; over the last four quarters revenue was $5.31M and net income −$13.7M; for the fiscal year ended December 2025 revenue was $3.94M, up 20.4% on the year before.
TNON annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $3.94M, gross profit $2.36M, operating income −$12.8M, net income −$12.6M (margin -318.4%), EPS −$1.70
- Fiscal year ended Dec 2024: revenue $3.28M, gross profit $1.71M, operating income −$13.8M, net income −$13.7M (margin -417.2%), EPS −$11.26
- Fiscal year ended Dec 2023: revenue $2.93M, gross profit $1.24M, operating income −$15.7M, net income −$15.6M (margin -532.1%), EPS −$68.64
- Fiscal year ended Dec 2022: revenue $691K, gross profit −$641K, operating income −$18.7M, net income −$18.9M (margin -2737.6%), EPS −$23.62
- Fiscal year ended Dec 2021: revenue $160K, gross profit $105K, operating income −$6.46M, net income −$7.05M (margin -4405.0%), EPS −$7.81
TNON quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $1.28M (up 126.8% year over year), net income −$4.05M, EPS −$12.35
- Quarter ended Mar 31, 2026: revenue $1.38M (up 89.9% year over year), net income −$3.48M, EPS $0.31
- Quarter ended Dec 31, 2025 (from the annual report): revenue $1.48M (up 92.3% year over year), net income −$2.83M, EPS $10.45
- Quarter ended Sep 30, 2025: revenue $1.17M (up 32.2% year over year), net income −$3.34M, EPS −$0.40
- Quarter ended Jun 30, 2025: revenue $564K (down 37.4% year over year), net income −$2.77M, EPS −$12.76
- Quarter ended Mar 31, 2025: revenue $726K (up 1.0% year over year), net income −$3.62M, EPS $1.01
- Quarter ended Dec 31, 2024 (from the annual report): revenue $770K (down 4.7% year over year), net income −$3.09M, EPS $10.55
- Quarter ended Sep 30, 2024: revenue $887K (down 6.0% year over year), net income −$3.18M, EPS −$3.63
- Quarter ended Jun 30, 2024: revenue $901K (up 21.3% year over year), net income −$3.83M, EPS −$8.16
- Quarter ended Mar 31, 2024: revenue $719K (up 66.1% year over year), net income −$3.58M, EPS −$10.02
- Quarter ended Dec 31, 2023 (from the annual report): revenue $808K (up 191.7% year over year), net income −$3.13M, EPS −$49.37
- Quarter ended Sep 30, 2023: revenue $944K (up 353.8% year over year), net income −$3.33M, EPS −$11.69
- Quarter ended Jun 30, 2023: revenue $743K (up 450.4% year over year), net income −$4.29M, EPS −$3.28
- Quarter ended Mar 31, 2023: revenue $433K (up 509.9% year over year), net income −$4.83M, EPS −$4.30
- Quarter ended Dec 31, 2022 (from the annual report): revenue $277K (up 422.6% year over year), net income −$7.91M, EPS −$17.77
- Quarter ended Sep 30, 2022: revenue $208K (up 197.1% year over year), net income −$3.17M, EPS −$2.82
- Quarter ended Jun 30, 2022: revenue $135K (up 513.6% year over year), net income −$5.49M, EPS −$0.65
- Quarter ended Mar 31, 2022: revenue $71.0K (up 373.3% year over year), net income −$2.35M, EPS −$2.38
- Quarter ended Dec 31, 2021 (from the annual report): revenue $53.0K, net income −$2.84M, EPS −$3.01
- Quarter ended Sep 30, 2021: revenue $70.0K, net income −$2.34M, EPS −$2.55
TNON cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$10.7M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$9.88M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$12.2M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$12.0M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$4.29M, share buybacks n/a
TNON balance sheet
- Jun 30, 2026: cash $1.68M, total assets $9.92M, total liabilities $11.7M, shareholders' equity −$1.74M
- Mar 31, 2026: cash $4.61M, total assets $12.8M, total liabilities $10.9M, shareholders' equity $1.90M
- Dec 31, 2025: cash $3.76M, total assets $10.8M, total liabilities $5.72M, shareholders' equity $5.04M
- Sep 30, 2025: cash $3.44M, total assets $10.4M, total liabilities $5.57M, shareholders' equity $4.80M
- Jun 30, 2025: cash $7.85M, total assets $11.1M, total liabilities $4.40M, shareholders' equity $6.71M
- Mar 31, 2025: cash $10.3M, total assets $13.4M, total liabilities $4.02M, shareholders' equity $9.38M
- Dec 31, 2024: cash $6.54M, total assets $9.84M, total liabilities $3.87M, shareholders' equity $5.97M
- Sep 30, 2024: cash $9.16M, total assets $13.0M, total liabilities $4.85M, shareholders' equity $8.19M
What is TNON's revenue?
TENON MEDICAL INC reported $5.31M of revenue over its last four quarters, through June 30, 2026.
Is TNON profitable?
No. TENON MEDICAL INC lost $13.7M over the last four quarters.
What is TNON's EPS?
Diluted earnings per share over the last four quarters were −$1.99; −$12.35 in the latest quarter.